Audentes Therapeutics, Inc. (Nasdaq: BOLD) announced today that it intends to offer $150.0 million of its common stock in an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE